Long-term Efficacy of Microwave Hyperthermia Combined with Chemoradiotherapy in Treatment of Nasopharyngeal Carcinoma with Cervical Lymph Node Metastases

  • Kang, Min (The First Affiliated Hospital of Guangxi Medical University) ;
  • Liu, Wen-Qi (The First Affiliated Hospital of Guangxi Medical University) ;
  • Qin, Yu-Tao (The First Affiliated Hospital of Guangxi Medical University) ;
  • Wei, Zhu-Xin (The First Affiliated Hospital of Guangxi Medical University) ;
  • Wang, Ren-Sheng (The First Affiliated Hospital of Guangxi Medical University)
  • Published : 2013.12.31


Objective: The long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treating nasopharyngeal carcinoma (NPC) with metastatic foci in cervical lymph nodes was evaluated. Methods: A total of 154 cases of N2 or N3 stage NPC were randomized into two groups: hyperthermia group (76 cases) and control group (78 cases). Both received cisplatin chemotherapy and radiotherapy. In addition, the hyperthermia group further received microwave hyperthermia to the metastatic cervical nodes with different patterns (before or after radiotherapy), heating temperatures (T90< $43^{\circ}C$ and $T90{\geq}43^{\circ}C$) and hyperthermia episodes (< 4 times, 4-10 times and > 10 times). Results: The 3-month and 5-year complete response (CR) rates of cervical lymph nodes in the hyperthermia group were significantly higher than those in the control group. The 5-year disease-free survival (DFS) rate and the 3-year / 5-year overall survival rate in the hyperthermia group were also significantly higher. There was no significant difference in 5-year metastatic rates. In the hyperthermia group, the 3-month and 5-year CR rates of T90< $43^{\circ}C$ treatment were significantly lower than with $T90{\geq}43^{\circ}C$ treatment. The CR rate was highest when the hyperthermia was performed 4-10 times. There were no significant differences in 3-month and 5-year CR rates between hyperthermia before or after radiotherapy treatment. Conclusion: Microwave hyperthermia combined with chemoradiotherapy can increase local control, DFS and 3, 5-year overall survival rates of patients with N2 ~ N3 stage NPC. The heating temperature should be over $43^{\circ}C$ with hyperthermia repeated 4-10 times.



  1. Chen J, Liu GG, Luo X (2009). Efficacy of radiotherapy plus microwave hyperthermia treatment for the neck fixed metastatic carcinoma. J Prac Oncol, 24, 487-9.
  2. Colombo R, Moschini M (2013). Role of the combined regimen with local chemotherapy and Mw-induced hyperthermia for non-muscle invasive bladder cancer management. A systematic review]. Urologia, 80, 112-9.
  3. Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 13, 1341-6.
  4. Erkal HS, Serin M, Cakmak A (2001). Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol, 61, 247-56.
  5. Fleming ID, Cooper JS, Henson DE, et al (1997). AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven.
  6. Ghahremani FH, Sazgarnia A, Bahreyni-Toosi MH, Rajabi O, Aledavood A (2011). Efficacy of microwave hyperthermia and chemotherapy in the presence of gold nanoparticles: an in vitro study on osteosarcoma. Int J Hyperthermia, 27, 625-36.
  7. Hei BW, Zhao YT, Zhang GF, et al (2002). An evaluation of short-term clinical effectiveness in the treatment of advanced esophageal carcinoma with radiotherapy, radio-frequency hyperthermia and immunotherapy. J South Yangtze Univ, 1, 425-8.
  8. Jen YM, Lin YS, Su WF, et al (2002). Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending? Int J Radiat Oncol Biol Phys, 54, 14-22.
  9. Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observation. J Am Stat Assoc, 53, 457-81.
  10. Kapp DS, Cox RS (1995).Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys, 33, 887-99.
  11. Lee AW, Sze WM, Yau TK, et al (2001). Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): Report on 3-year tumor control and normal tissue toxicity. Radiother Oncol, 58, 121-30.
  12. Levendag PC, Lagerwaard FJ, de Pan C, et al (2002). High-dose, high-precision treatment options for boosting cancer of the nasopharynx. Radiother Oncol, 63, 67-74.
  13. Li DJ, Hu ZX (1995). Hyperthermia science [M]. Henan Medical University Press, 8, 366-9.
  14. Li G, Mitsumori M, Ogura M (2004). Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. Int J Clin Oncol, 9, 179-83.
  15. Li ZQ, Zhang WM, Li J, et al (2004). Curative effect of radiochemical therapy and hyperthermia therapy for nasopharyngeal carcinoma with cervical lymph node metastasis. J Prac Med, 20, 532-3.
  16. Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY (2003). Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol, 33, 501-8.
  17. Liu SX, Chen DX, Zhang SJ, et al (1997). The treatment of nasopharyngeal carcinoma by using thermoradiotherapy. J Clin Otorhinolaryngol, 11, 150-2.
  18. Liu YS, Niu JW, Zhang WH, et al (2005). The experimental study of the effects of radiotherapy combined with hyperthermia on the HeLa Cells of cervical carcinoma in laboratory. J Cap Univ Med Sci, 26, 593-6.
  19. Lu H, Yao M (2008). The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev, 34, 27-36.
  20. Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, Christophi C (2005). The apoptotic response of liver and colorectal liver metastases to focal hyperthermic injury. Anticancer Res, 25, 1413-9.
  21. Perez CA, Brady LW (1987). Hyperthermia Principles and Practice of Radiation oncology. JB Lippincott Company, 317-52.
  22. Roychowdhury DF, Tseng AJr, Fu KK, Weinburg V, Weidner N (1996). New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer, 77, 1419-26.<1419::AID-CNCR1>3.0.CO;2-7
  23. Song LQ, Wang XJ, Guan HT, et al (2006). Study of high power microwave hyperthermia combined with chemotherapy in the treatment of patients with advanced cancer. Shanxi Med J, 11, 1437-9.
  24. Tate DJ, Adler JR, Chang SD, et al (1999). Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys, 45, 915-21.
  25. Teo PM, Leung SF, Chan AT, et al (2000). Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys, 48, 1311-22.
  26. Wolden SL, Zelefsky MJ, Hunt MA, et al (2001). Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 49, 1229-34.
  27. Yin WB, Yu ZH, Xu GZ, et al (2008). Radiation oncology [M]. Fourth edition. Beijing: China Union Medical University Press, 451. [in Chinese].
  28. Zastrow E, Hagness SC, Van Veen BD (2010). 3D computational study of non-invasive patient-specific microwave hyperthermia treatment of breast cancer. Phys Med Biol, 55, 3611-29.
  29. Zheng Z, Zhang Y, Pan JJ, et al (2006). Results of hyperthermia for cervical lymph node metastasis in nasopharyngeal carcinoma. J Fujian Med Univ, 40, 629-31.

Cited by

  1. Glycididazole Sodium Combined with Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma vol.15, pp.6, 2014,
  2. Selective Radiotherapy after Distant Metastasis of Nasopharyngeal Carcinoma Treated with Dose-Dense Cisplatin plus Fluorouracil vol.16, pp.14, 2015,
  3. Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis vol.32, pp.1, 2016,
  4. Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary? vol.7, pp.2234-943X, 2017,